Metformin Improves Dopamine Release and Motor Performance in C57BL/6N Mice induced by MPTP: Insights of Alternative Medication for Parkinson’s Disease

Journal Title: Advances in Clinical Toxicology - Year 2020, Vol 5, Issue 1

Abstract

It is obvious that Levodopa can effectively ameliorate most of the motor symptoms associated with Parkinson’s disease. However, Levodopa-induced dyskinesia (LID) experienced due to its long-term usage poses a great concern over it is dependency. Alternative therapies that can equally improve and/or cure the motor symptoms without alarming side effects are unarguably needed. Recently, Metformin, besides being a key player in the management of Diabetes Mellitus type 2 (T2DM), was also found to have some potentials in the treatment of Parkinson’s disease (PD). In this study, MPTP (1-methyl4-phenyl-1,2,3,6-tetrahydropyridine) were used to create the PD models (an established fact supported by multiple studies). Initially, C57BL/6N mice were randomly divided into 3 groups (Saline, MPTP, MPTP + Metformin) (n=8, each). Later, MPTP + Metformin group was further sub-divided into 3 and 100, 200; 400 mg/kg metformin was administered to each sub-group accordingly. After a series of behavioral assays, the mice were sacrificed and the brain was taken out to measure the DA release in the striatum using carbon-fiber electrode (amperometric recording). In each case, Metformin proves to be decisive and display convincing/satisfactory results depicting its neuroprotective prowess.

Authors and Affiliations

Ishaq DU*, Kurfi BG and Aliyu M

Keywords

Related Articles

Carboxylic Acid & Alzheimer’s Disease

In this paper we consider the possible connection between carboxylic acid and Alzheimer’s disease. There appreas to be a possible link whereas the neurotransmitter acetylcholine depleted in Alzheimer’s patients may b...

Malaria Tests-DNA PCR and Quantitative Buffy Coat (QBC)

Malaria, considered a tropical disease, poses a significant threat to public health especially in Sub-Saharan Africa [1]. It is a blood borne disease caused by a protozoan parasite called plasmodium [1,2]. Being blood...

Review-Influence of Nanomaterials on Cellular Stress, and Cellular Behavior

The cellular responses to stress are a complex phenomenon. These have faced varied impacts of the advancements in biomolecular, cellular and biomedical fields that have taken place from time to time. Nanotechnology and...

Protective Effect of Protocatechuic Acid in Genotoxicity-Induced by Carbon Tetrachloride: A Preliminary Study

Carbon tetrachloride (CCl4) is commonly utilized as a solvent, a refrigerant, and a dry-cleaning agent. However, its genotoxic effect has been well documented. The present work was designed to assess the genotoxic effect...

Effect of 17α-Ethinylestradiol on the Intestinal Calcium Carbonate Excretion Rate of Yellow Fin Sea Bream (Acanthopagrus latus)

Marine fish maintain their hypotonic body fluids by drinking seawater, excreting excess salt, and retaining water. Calcium in seawater is precipitated as CaCO3 in marine fish gut to limit the Ca2+ availability for absorp...

Download PDF file
  • EP ID EP751699
  • DOI 10.23880/act-16000178
  • Views 53
  • Downloads 0

How To Cite

Ishaq DU*, Kurfi BG and Aliyu M (2020). Metformin Improves Dopamine Release and Motor Performance in C57BL/6N Mice induced by MPTP: Insights of Alternative Medication for Parkinson’s Disease. Advances in Clinical Toxicology, 5(1), -. https://europub.co.uk/articles/-A-751699